Foamix Pharmaceuticals Ltd. — key financial figures for fiscal year 2019 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2019)

$443.0K

Net Income/Loss (FY2019)

-$95.2M

Total Assets (FY2019)

$81.2M

Total Equity (FY2019)

$17.6M

Cash Flows from Operating Activities (FY2019)

-$73.4M

Source: Foamix Pharmaceuticals Ltd. 10-K filing (FY2019). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.